Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
ELEVAR
Show more
Research and development of experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients
Class 44 – Medical & beauty services
Status timeline
- 16 Aug 2019Application filedNew Application Entered
- 12 Nov 2019Assigned to an examining attorneyAssigned To Examiner
- 15 Nov 2019Office action issuedNon-Final Action Written
- 15 May 2020Response to office action filedTeas Response To Office Action Received
- 16 Jun 2020Final refusal issuedFinal Refusal Mailed
- 20 Aug 2020Office action issuedNon-Final Action Written
- 9 Feb 2021Response to office action filedTeas Response To Office Action Received
- 10 Mar 2021Approved for publicationApproved For Pub - Principal Register
- 13 Apr 2021Published for oppositionPublished For Opposition
- 8 Jun 2021Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 8 Dec 2021Statement-of-use extension 1 grantedSou Extension 1 Granted
- 15 Jun 2022Statement-of-use extension 2 grantedSou Extension 2 Granted
- 8 Dec 2022Statement-of-use extension 3 grantedSou Extension 3 Granted
- 8 Dec 2023Statement of use filedTeas Statement Of Use Received
- 15 Feb 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 16 Feb 2024Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 26 Nov 2024Registered on the Principal RegisterRegistered-Principal Register
All 60 events
| 2024-11-26 | Registered-Principal Register |
| 2024-11-26 | Notice Of Registration Confirmation Emailed |
| 2024-02-16 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-02-16 | On Hold - Electronic Record Review Required |
| 2024-02-15 | Allowed Principal Register - Sou Accepted |
| 2023-12-11 | Divisional Processing Complete |
| 2023-12-11 | Statement Of Use Processing Complete |
| 2023-12-08 | Teas Statement Of Use Received |
| 2023-12-08 | Teas Request To Divide Received |
| 2023-12-08 | Divisional Request Received |
| 2023-12-08 | Use Amendment Filed |
| 2023-06-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-06-08 | Sou Teas Extension Received |
| 2023-06-08 | Sou Extension 4 Filed |
| 2023-06-08 | Sou Extension 4 Granted |
| 2023-06-07 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2023-06-07 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2023-06-07 | Teas Change Of Correspondence Received |
| 2022-12-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2022-12-08 | Sou Teas Extension Received |
| 2022-12-08 | Sou Extension 3 Filed |
| 2022-12-08 | Sou Extension 3 Granted |
| 2022-06-16 | Notice Of Approval Of Extension Request E-Mailed |
| 2022-06-15 | Case Assigned To Intent To Use Paralegal |
| 2022-06-15 | Sou Extension 2 Granted |
| 2022-06-08 | Teas Change Of Owner Address Received |
| 2022-06-08 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2022-06-08 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2022-06-08 | Teas Change Of Correspondence Received |
| 2022-06-08 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2022-06-08 | Sou Teas Extension Received |
| 2022-06-08 | Sou Extension 2 Filed |
| 2021-12-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2021-12-08 | Sou Teas Extension Received |
| 2021-12-08 | Sou Extension 1 Filed |
| 2021-12-08 | Sou Extension 1 Granted |
| 2021-06-08 | Noa Mailed - Sou Required From Applicant |
| 2021-04-13 | Published For Opposition |
| 2021-04-13 | Official Gazette Publication Confirmation E-Mailed |
| 2021-03-24 | Notification Of Notice Of Publication E-Mailed |
| 2021-03-10 | Approved For Pub - Principal Register |
| 2021-02-10 | Teas/Email Correspondence Entered |
| 2021-02-09 | Teas Response To Office Action Received |
| 2021-02-09 | Correspondence Received In Law Office |
| 2020-08-20 | Non-Final Action Written |
| 2020-08-20 | Non-Final Action E-Mailed |
| 2020-08-20 | Notification Of Non-Final Action E-Mailed |
| 2020-06-16 | Final Refusal Mailed |
| 2020-06-16 | Final Refusal E-Mailed |
| 2020-06-16 | Notification Of Final Refusal Emailed |
| 2020-05-21 | Assigned To Lie |
| 2020-05-21 | Correspondence Received In Law Office |
| 2020-05-21 | Teas/Email Correspondence Entered |
| 2020-05-15 | Teas Response To Office Action Received |
| 2019-11-15 | Non-Final Action Written |
| 2019-11-15 | Non-Final Action E-Mailed |
| 2019-11-15 | Notification Of Non-Final Action E-Mailed |
| 2019-11-12 | Assigned To Examiner |
| 2019-08-28 | New Application Office Supplied Data Entered |
| 2019-08-16 | New Application Entered |
Goods & services by class
Class 44 Medical & beauty services
Research and development of experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients
First use anywhere 16 Oct 2019 · First use in commerce 16 Oct 2019
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 26 Nov 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.